A bio-printing company based in San Diego is expecting to unveil the world's first printed organ - a human liver - by next year.
The major stumbling block in creating tissue has remained with manufacturing of the vascular system that is needed to provide it with life-sustaining oxygen and nutrients.
Organovo, however, said that it has been able to overcome that vascular issue to a degree.
Mike Renard, Organovo's executive vice president of commercial operations, said that they were able to achieve thicknesses more than 500 microns, and were able to maintain liver tissue in a fully functional state with native phenotypic behavior for at least 40 days, PC World reported.
Renard said that the researchers were able to bring together fibroblasts and endothelial cells, which perform the function of developing tiny vascular networks, allowing the company to achieve thick tissue with good cell viability.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
